Tavneos (avacopan) approved for ANCA associated vasculitis in Japan
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
Industry leaders to increase patient access to clinical research and scale remote enrollment of participants for trial sponsors to promote increased health equity
New Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline the transition from research to clinical environments
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
It comes with a prime focus on infection control and patient flow as the primary infrastructure design aspects - the need of the hour and must-have during a pandemic.
Subscribe To Our Newsletter & Stay Updated